Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
You may find your answer here, under Plan of Arrangement, Pages 7 and 8.
https://www.resverlogix.com/upload/media_element/48/798f19de476a/mda-resverlogix-corp-2015-04-30-2015.07.24.pdf
Koo